Dr. Dinesh Singh

Senior Consultant Radiation Oncology


About Dr. Dinesh Singh :

Best Radiation Oncologist in Delhi, Dr. Dinesh Singh, brings a wealth of expertise with an illustrious career. Trained at prestigious institutions like Memorial Sloan Kettering Cancer Center in NY, USA, and holding degrees in MBBS and MD from Delhi University, Dr. Singh has left an indelible mark. Renowned for pioneering interstitial HDR brachytherapy for recurrent GBM, he has also played a pivotal role in establishing radiation oncology departments at esteemed institutions in Delhi. As a Founder Member of Indian Cooperative Oncology Network (ICON) and Delhi Neuro Oncology Society, and Secretary of the Men’s Health Society Delhi Chapter, Dr. Dinesh Singh is a distinguished leader actively shaping the landscape of oncology in India. Currently Associated with Valentis Cancer Hospital as a Medical Director and Radiation Oncologist.

Education :

  • MBBS , University College of Medical Sciences & GTB Hospital New Delhi , 1986
  • MD-Radio Therapy , Maulana Azad Medical College New Delhi , 1991
  • Training at Memorial Sloan Kettering Cancer Center, NY, USA
  • Training at Ohio State University OH, USA
  • Training at UTMB, Galveston, USA
  • Training at LBMMC, CA, USA
  • Training at Orange County CyberKnife Centre, CA, USA
  • Training at Offerback University, Frankfurt, Germany

Special Expertise :

  • Breast Cancer
  • Tumors
  • Testicular Cancer
  • Chemotherapy
  • Blood Cancer
  • Brain Tumor
  • Lung Cancer
  • Colon Cancer
  • Cancer Pain
  • Oral Cancer
  • Prostate Cancer
  • Liver Cancer
  • Throat Cancer

Total Years of Experience :

Over 38 Years of Overall Experience

Awards & Honours :

  • Member of INCTR
  • Member of Association of Radiation Oncologists of India
  • Member of Indian Society of Oncology
  • Member of Indian Medical Association (IMA)
  • Founder Member of Indian Cooperative Oncology Network (ICON)
  • Member of Delhi Neuro oncology Society
  • Secretary, Men’s Health Society Delhi Chapter

Paper Presentation /Conferences /Workshops :

  • Conducted Phase II dose escalation study on 2 DG in Glioblastoma Multiforme and published in Strelentherapy Oncology
  • Conducted a study on concurrent chemoradiotherapy in head and neck cancer, published in INCTR abstract book
  • Conducted a study on concurrent temozolomide and radiotherapy in GBM
  • Explored the role of interstitial brachytherapy in GBM and presented findings in Asia Pacific Cancer Congress

Book Appointment